American Journal of Cardiology
Volume 100, Issue 7 , Pages 1114-1118 , 1 October 2007

Utilization of Distal Embolic Protection in Saphenous Vein Graft Interventions (An Analysis of 19,546 Patients in the American College of Cardiology–National Cardiovascular Data Registry)

  • Sameer K. Mehta, MD

      Affiliations

    • Department of Cardiology, The Mid America Heart Institute, Kansas City, Missouri
    • ,
  • Andrew D. Frutkin, MD

      Affiliations

    • Department of Cardiology, The Mid America Heart Institute, Kansas City, Missouri
    • ,
  • Sarah Milford-Beland, MS

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Lloyd W. Klein, MD

      Affiliations

    • Department of Cardiology, Rush-Presbyterian-St. Luke’s Medical Center, Chicago, Illinois
    • ,
  • Richard E. Shaw, PhD

      Affiliations

    • Department of Clinical Research, Sutter Pacific Heart Centers, San Francisco, California
    • ,
  • William S. Weintraub, MD

      Affiliations

    • Department of Outcomes Research, Christiana Care Health Systems, Atlanta, Georgia
    • ,
  • Ronald J. Krone, MD

      Affiliations

    • Department of Cardiology, Washington University, St. Louis, Missouri
    • ,
  • H. Vernon Anderson, MD

      Affiliations

    • Department of Cardiology, University of Texas Health Science Center, Houston, Texas
    • ,
  • Michael A. Kutcher, MD

      Affiliations

    • Department of Cardiology, Wake Forest University Health Sciences, Winston-Salem, North Carolina.
    • ,
  • Steven P. Marso, MD

      Affiliations

    • Department of Cardiology, The Mid America Heart Institute, Kansas City, Missouri
    • Corresponding Author InformationCorresponding author: Tel: 816-932-5798; fax: 816-932-5773.

Received 21 February 2007 ,Revised 17 April 2007 ,Accepted 25 April 2007.

References 

  1. Baim DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation. 2002;105:1285–1290
  2. Stone GW, Rogers C, Hermiller J, Feldman R, Hall P, Haber R, et al Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation. 2003;108:548–553
  3. Cohen DJ, Murphy SA, Baim DS, Lavelle TA, Berezin RH, Cutlip DE, et al. Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial. J Am Coll Cardiol. 2004;44:1801–1808
  4. Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB, et al ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation. 2006;113:e166–e286
  5. Webb LA, Dixon SR, Safian RD, O’Neill WW. Usefulness of embolic protection devices during saphenous vein graft intervention in a nonselected population. J Interv Cardiol. 2005;18:73–75
  6. Mathew V, Lennon RJ, Rihal CS, Bresnahan JF, Holmes DR. Applicability of distal protection for aortocoronary vein graft interventions in clinical practice. Cathet Cardiovasc Intervent. 2004;63:148–151
  7. Brindis RG, Fitzgerald S, Anderson HV, Shaw RE, Weintraub WS, Williams JF. The American College of Cardiology–National Cardiovascular Data Registry (ACC-NCDR): building a national clinical data repository. J Am Coll Cardiol. 2001;37:2240–2245
  8. Weintraub WS, McKay CR, Riner RN, Ellis SG, Frommer PL, Carmichael DB, et al. The American College of Cardiology National Database: progress and challenges (American College of Cardiology Database Committee). J Am Coll Cardiol. 1997;29:459–465
  9. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings. N Engl J Med. 1985;312:932–936
  10. Moscucci M, Share D, Smith D, O’Donnell MJ, Riba A, McNamara R, et al Relationship between operator volume and adverse outcome in contemporary percutaneous coronary intervention practice: an analysis of a quality-controlled multicenter percutaneous coronary intervention clinical database. J Am Coll Cardiol. 2005;46:625–632
  11. Canto JG, Every NR, Magid DJ, Rogers WJ, Malmgren JA, Frederick PD, et al. The volume of primary angioplasty procedures and survival after acute myocardial infarction (National Registry of Myocardial Infarction 2 Investigators). N Engl J Med. 2000;342:1573–1580
  12. Magid DJ, Calonge BN, Rumsfeld JS, Canto JG, Frederick PD, Every NR, et al. Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy. JAMA. 2000;284:3131–3138
  13. McGrath PD, Wennberg DE, Dickens JD, Siewers AE, Lucas FL, Malenka DJ, et al. Relation between operator and hospital volume and outcomes following percutaneous coronary interventions in the era of the coronary stent. JAMA. 2000;284:3139–3144
  14. Giugliano GR, Kuntz RE, Popma JJ, Cutlip DE, Baim DS. Determinants of 30-day adverse events following saphenous vein graft intervention with and without a distal occlusion embolic protection device. Am J Cardiol. 2005;95:173–177
  15. Hong MK, Mehran R, Dangas G, Mintz GS, Lansky AJ, Pichard AD, et al. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation. 1999;100:2400–2405

PII: S0002-9149(07)01254-4

doi: 10.1016/j.amjcard.2007.04.058

American Journal of Cardiology
Volume 100, Issue 7 , Pages 1114-1118 , 1 October 2007

Article Tools

* Image Usage & Resolution